{"id":"https://openalex.org/W2359518362","doi":null,"title":"Safety and effectiveness of ustekinumab for treatment of moderate to severe psoriasis: a prospective study in a clinical setting.","display_name":"Safety and effectiveness of ustekinumab for treatment of moderate to severe psoriasis: a prospective study in a clinical setting.","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-01","ids":{"openalex":"https://openalex.org/W2359518362","mag":"2359518362","pmid":"https://pubmed.ncbi.nlm.nih.gov/25116977"},"language":"en","primary_location":{"id":"pmid:25116977","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25116977","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2359518362"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069500810","display_name":"Alejandro Molina\u2010Leyva","orcid":"https://orcid.org/0000-0001-6882-2113","observed_orcids":["https://orcid.org/0000-0001-6882-2113"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alejandro Molina-Leyva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056447112","display_name":"Husein Husein\u2010ElAhmed","orcid":"https://orcid.org/0000-0001-7869-0206","observed_orcids":["https://orcid.org/0000-0001-7869-0206"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Husein Husein-Elahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045543780","display_name":"Ram\u00f3n Naranjo\u2010Sintes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ramon Naranjo-Sintes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088253349","display_name":"Jos\u00e9 Carlos Ruiz\u2010Carrascosa","orcid":"https://orcid.org/0000-0002-9312-7259","observed_orcids":["https://orcid.org/0000-0002-9312-7259"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jose Carlos Ruiz-Carrascosa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7287,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.65532511,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"13","issue":"8","first_page":"971","last_page":"974"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pasi-response","display_name":"PASI response","score":0.6629999876022339},{"id":"https://openalex.org/keywords/pasi-75","display_name":"PASI 75","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pasi-90","display_name":"PASI 90","score":0.996999979019165},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5230000019073486},{"id":"https://openalex.org/keywords/psoriasis-severity","display_name":"psoriasis severity","score":0.6549999713897705},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6850000023841858},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.9827362298965454},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9630085229873657},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8585128784179688},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5502241253852844},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.49979448318481445},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.43969401717185974},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.42877498269081116},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.42323198914527893},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.4106937348842621},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.40099582076072693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40035757422447205},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.23057898879051208},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.1609465479850769},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.09912517666816711}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008499","descriptor_name":"Medical Records","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25116977","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25116977","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},{"id":"mag:2359518362","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25116977","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2999643437","https://openalex.org/W3173625493","https://openalex.org/W1824004770","https://openalex.org/W4240867700","https://openalex.org/W4246081471","https://openalex.org/W2167282320","https://openalex.org/W2936320427","https://openalex.org/W2109633277","https://openalex.org/W1535196230","https://openalex.org/W2930792999"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"are":[2,159],"few":[3],"studies":[4],"analyzing":[5],"the":[6,11,24,35,40,152,165],"behavior":[7],"of":[8,14,26,34,42,82,84,173],"ustekinumab":[9,27,49,158],"in":[10,28,168,191],"complex":[12],"management":[13],"psoriasis":[15,30,45,174],"within":[16],"diary":[17],"clinical":[18,150,169],"practice":[19],"setting.":[20],"OBJECTIVE:":[21],"To":[22],"assess":[23],"utility":[25],"a":[29,51,80,133,194],"unit.":[31],"METHODS:":[32],"Analysis":[33],"prospective":[36],"data":[37,166],"gathered":[38],"during":[39],"follow-up":[41],"30":[43],"consecutive":[44],"patients":[46,96,124,131],"treated":[47,146],"with":[48,132,178],"at":[50,75,79,104],"single":[52],"referral":[53],"centre.":[54],"Three":[55],"effectiveness":[56],"endpoints":[57],"were":[58,119],"defined":[59],"12":[60],"weeks,":[61],"28":[62,77],"and":[63,78,94,100,113,116,130,140,154,161,185],"\"long-term":[64,89],"treatment\".":[65,90],"The":[66],"main":[67],"outcome":[68],"measure":[69],"was":[70],"improvement":[71],"from":[72],"baseline":[73,134],"PASI":[74,135,192],"week":[76,105,122],"point":[81],"adjustment":[83],"prolonged":[85],"treatment":[86,108,187],"signed":[87],"as":[88],"RESULTS:":[91],"Overall":[92],"82.1%":[93],"42.8%":[95],"achieved":[97],"respectively":[98,118],"PASI75":[99,115,139],"PASI90":[101,141],"response":[102,142],"rates":[103,143],"28.":[106],"Long-term":[107],"maintained":[109],"efficacy":[110,153],"outcomes":[111],"81.5%":[112],"40.7%":[114],"PASI90,":[117],"observed.":[120],"At":[121],"28,":[123],"na\u00efve":[125],"to":[126,157,164],"TNF\u03b1-":[127],"blockers":[128,183],"agents":[129,184],">10":[136],"had":[137],"better":[138,163],"than":[144],"previously":[145],"patients.":[147],"CONCLUSIONS:":[148],"In":[149],"practice,":[151],"patient":[155],"adherence":[156],"excellent":[160],"even":[162],"obtained":[167],"trials.":[170],"Clinical":[171],"indicators":[172],"severity:":[175],"previous":[176],"treatments":[177],"tumor":[179],"necrosis":[180],"factor":[181],"\u03b1":[182],"active":[186],"beside":[188],"small":[189],"increases":[190],"determine":[193],"delayed":[195],"maximal":[196],"response.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2359518362","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
